Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Outset Medical, Inc. OM | PFM Health Sciences LP | 0 0.000% | -196,017 (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | PFM Health Sciences LP | 29,061,060 3.000% | -25,597,620 (-46.83%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | PFM Health Sciences LP | 185,164 5.900% | 19,862 (+12.02%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | PFM Health Sciences LP | 2,703,287 3.700% | -1,229,946 (-31.27%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | uniQure N.V. QURE | PFM Health Sciences LP | 2,302,314 4.900% | -90,997 (-3.80%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,459,783 7.300% | 367,474 (+8.98%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Erasca, Inc. ERAS | PFM Health Sciences LP | 4,797,460 3.200% | -2,953,028 (-38.10%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | PFM Health Sciences LP | 1,391,831 3.200% | -767,902 (-35.56%) | Filing History |
| 2023-02-14 4:06 pm Unchanged | 2022-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 0 (Unchanged) | Filing History |
| 2023-01-17 4:01 pm Purchase | 2023-01-06 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,821,820 5.300% | 528,527 (+40.87%) | Filing History |
| 2023-01-17 1:20 pm Sale | 2022-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,293,293 4.200% | -223,733 (-14.75%) | Filing History |
| 2022-11-10 4:02 pm Purchase | 2022-10-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,844,332 8.700% | 3,844,332 (New Position) | Filing History |
| 2022-10-24 4:01 pm Purchase | 2022-10-14 | 13G | Axsome Therapeutics, Inc. AXSM | PFM Health Sciences LP | 2,159,733 5.400% | 2,159,733 (New Position) | Filing History |
| 2022-10-17 4:01 pm Purchase | 2022-10-06 | 13G | Arcus Biosciences, Inc. RCUS | PFM Health Sciences LP | 3,933,233 5.500% | 502,223 (+14.64%) | Filing History |
| 2022-09-06 4:02 pm Purchase | 2022-08-26 | 13G | Erasca, Inc. ERAS | PFM Health Sciences LP | 7,750,488 6.300% | 7,750,488 (New Position) | Filing History |
| 2022-09-06 4:01 pm Purchase | 2022-08-25 | 13G | Generation Bio Co. GBIO | PFM Health Sciences LP | 301,371 5.100% | 301,371 (New Position) | Filing History |
| 2022-07-18 4:11 pm Purchase | 2022-07-07 | 13G | uniQure N.V. QURE | PFM Health Sciences LP | 2,393,311 5.100% | 2,393,311 (New Position) | Filing History |
| 2022-06-17 4:21 pm Purchase | 2022-06-07 | 13G | Praxis Precision Medicines, Inc. PRAX | PFM Health Sciences LP | 165,302 5.400% | 165,302 (New Position) | Filing History |
| 2022-05-09 4:51 pm Purchase | 2022-04-28 | 13G | Adaptimmune Therapeutics plc ADAP | PFM Health Sciences LP | 54,658,680 5.800% | 54,658,680 (New Position) | Filing History |
| 2022-05-02 4:02 pm Purchase | 2022-04-21 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 1,517,026 5.500% | 1,517,026 (New Position) | Filing History |